medigraphic.com
ISSN 0187-5337 (Impreso)
Instituto Nacional de Perinatología

2002, Número 4

<< Anterior Siguiente >>

Perinatol Reprod Hum 2002; 16 (4)


Polidactilia preaxial en recién nacidos expuestos a ácido valproico durante el embarazo: presentación de dos casos

Aguinaga-Ríos M, Llano-Rivas I, Mayén-Molina DG, García-Cavazos R

Idioma: Español
Referencias bibliográficas: 27
Paginas: 180-186
Archivo PDF: 731.11 Kb.


RESUMEN

La exposición a ácido valproico durante el embarazo se ha asociado con la presencia de defectos faciales menores y varios defectos mayores como defecto en el cierre del tubo neural, alteraciones cardiacas, urogenitales, musculares y esqueléticas.
En el presente estudio se informan dos recién nacidos expuestos a valproato durante el embarazo con la presencia de polidactilia preaxial en manos.


REFERENCIAS (EN ESTE ARTÍCULO)

  1. Perucca E. Pharmacologic and therapeutic properties of valproate: a summary after 35 years of clinical experience. CNS Drugs 2002; 16: 695-714.

  2. Briggs GG, Freeman RK, Yaffe SJ. Drugs in pregnancy and lactation: A reference guide to fetal and neonatal risk. Baltimore: Williams and Wilkins; 1999.

  3. Clayton-Smith J, Donnai D. Fetal valproate syndrome. J Med Genet 1995; 32: 724-7.

  4. Hanson JW, Myrianthopoulos NC, Harvey MA, Smith DW. Risks to the offspring of women treated with hydantoin anticonvulsants, with emphasis on the fetal hydantoin syndrome. J Pediatr 1976; 89: 662-8.

  5. Sharony R, Garber A, Viskochil D. Preaxial ray reduction defects as part of valproic acid embryopathy. Pren Diagn 1993; 13: 909-18.

  6. Dalens B, Raynaud E-J, Gaulme J. Teratogenicity of valproic acid. J Pediatr 1980; 97: 332-3.

  7. Omtzigt JG, Los FJ, Grobbee DE, Pijpers L, Jahoda MGJ, Brahoenburg H. The risk of spina bifida aperta after first trimester valproate exposure in a prenatal cohort. Neurology 1992; 42(Suppl. 5): 119-25.

  8. Gaily E, Granstrom M-L, Hiilesmaa V. Minor anomalies in offspring of epileptic mothers. J Pediatr 1988; 112: 520-9.

  9. DiLiberti JH, Farndon PA, Dennis NR. The fetal valproate syndrome. Am J Med Genet 1984; 19: 473-81.

  10. Shorvon S. Antiepileptic drug therapy during pregnancy: the neurologist’s perspective. J Med Genet 2002; 39: 248-50.

  11. Faiella A, Wernig M, Giacomo G, Hostick U, Hofmann C, Hustert E, Boncinelli E, Balling R, Nadeau J. A mouse model for valproate teratogenicity: parental effects, homeotic transformations, and altered HOX expression. Hum Mol Genet 2000; 19: 227-36.

  12. Chen G, Yuan PX, Jiang YM, Huang LD, Manji HK. Valproate robustly enhances AP-1 mediated gene expression. Brain Res Mol Brain Res 1999; 64: 52-8.

  13. Graham J Jr, Brown FE, Hall BD. Thumb polydactyly as a part of the range of genetic expression for thenar hypoplasia. Clin Pediatr 1987; 26: 142.

  14. Stevenson R, Hall J, Goodman R. Human malformations and related anomalies. Vol. II. New York: Oxford University Press; 1983.

  15. Holmes LB. The teratogenicity of anticonvulsant drugs: A progress study. J Med Genet 2002; 39: 245-7.

  16. McFadden DG, Mc Anally J, Richardson JA, Charite J, Olson E. Development 2002; 129: 3077-88.

  17. Koch S, et al. Possible teratogenic effect of valproate during pregnancy. J Pediatr 1983; 103: 1007-8.

  18. Knight AH, Rhind EG. Epilepsy and pregnancy: a study of 153 pregnancies in 59 patients. Epilepsia 1975; 26: 631-5.

  19. Holmes LB, Harvey EA, Coull BA, Huntington KB, Khoshbin S, Hayes AM, et al. The teratogenicity of anticonvulsant drugs. N Engl J Med 2001; 344: 1132-8.

  20. Yerby MS. Pregnancy, teratogenesis and epilepsy . Neurol Clin 1994; 12: 749-71.

  21. Hiilesmaa VK, Teramo K, Granstrom ML, et al. Serum folate concentrations during pregnancy in women with epilepsy: Relation to antiepileptic drug concentrations, number of seizures, and fetal outcome. Br Med J 1983; 287: 577-9.

  22. Chen B, Wang JF, Hill BC, Young LT. Lithium and valproate differentially regulate brain regional expression of phosphorylated CREB and c-fos. Brain Res Mol Brain Res 1999; 70: 45-53.

  23. Clay SA, McVie R, Chen HC. Possible teratogenic effect of valproic acid. J Pediatr 1981; 99: 828.

  24. Jäger-Roman E, Deichl A, Jakob S. Fetal growth major malformations and minor anomalies in infants born to women receiving valproic acid. J Pediatr 1986; 108: 887-1004.

  25. Bailey J, Pool RW. Valproic acid and fetal abnormality. Br Med J 1982; 286: 190.

  26. Colls P, Blanco J, Martínez-Pasarell O, Vidal F, Egozcue J, Márquez C, Guitart M, Templado C. Chromosome segregation in a man heterozygous for a pericentric inversion, inv(9)(p11q13), analyzed by using sperm karyotyping and two-color fluorescence in situ hybridization on sperm nuclei. Hum Genet 1997; 99: 761-5.

  27. Gardner RJM and Sutherland GR. Chromosome abnormalities and genetic counseling. Oxford: University Press; 1989.




2020     |     www.medigraphic.com